Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02301455 · ClinicalTrials.gov registry record · NA

REACH OUT: to Reduce High Blood Pressure in the Emergency Department

A NA study of Hypertension and Stroke, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
104
Enrollment target
1
Study location

NCT02301455: Completed NA study of Hypertension and Stroke, sponsored by University of Michigan.

NCT02301455 is a NA study of Hypertension and Stroke that has completed, run by University of Michigan. The registered enrollment target is 104 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02301455, a NA study of Hypertension and Stroke, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
104 participants
Enrollment target
1
Study location

Study Summary

One of the most powerful predictors of stroke is hypertension, with estimates of approximately 33% of adults in the United States experiencing this condition. Hypertension is very prevalent in the emergency department (ED), but significantly undertreated. The overall goal of this project is to develop a text messaging intervention to improve hypertension care in the ED. This will first be done by testing the feasibility of identifying hypertensive patients in the ED, and the response rate to text messages.

Conditions Studied

Interventions

  • BEHAVIORAL Text messaging

Study Locations (1)

Michigan

  • - Ann Arbor

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2014-10
Est. Completion 2015-08
Phase NA
University of Michigan

1,327 total trials

What the finished NCT02301455 record still lists

NCT02301455 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Text messaging is the first listed.

NCT02301455 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT02301455 about?

NCT02301455 is a clinical study titled "REACH OUT: to Reduce High Blood Pressure in the Emergency Department". One of the most powerful predictors of stroke is hypertension, with estimates of approximately 33% of adults in the United States experiencing this condition. Hypertension is very prevalent in the emergency department (ED), but significantly undertreated. The overall goal of this project is to deve...

What is the current status of trial NCT02301455?

This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2014-10. Estimated completion is 2015-08.

What conditions does trial NCT02301455 study?

This clinical trial studies the following conditions: Hypertension, Stroke.

What interventions are being tested in trial NCT02301455?

The interventions under investigation include: Text messaging (BEHAVIORAL).

Who is sponsoring clinical trial NCT02301455?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02301455 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02301455's enrollment target sits among peer trials

104 290th of 470 higher than 181 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03403686 · 104 participants

    Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

  • NCT04228367 · 104 participants · NA

    JuggerStitch Post Market Clinical Follow-up Study

  • NCT04268849 · 104 participants · Phase 3

    Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

  • NCT04390724 · 104 participants

    Optimizing Y90 Therapy for Radiation Lobectomy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02301455, the US trial registry maintained by the National Library of Medicine. NCT02301455 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.